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Abstract
Background: Alternative selection of splice sites in tandem donors and acceptors is a major mode
of alternative splicing. Here, we analyzed whether in-frame tandem sites leading to subtle mRNA
insertions/deletions of 3, 6, or 9 nucleotides are under natural selection.
Results: We found multiple lines of evidence that the human protein coding sequences are under
selection against such in-frame tandem splice events, indicating that these events are often
deleterious. The strength of selection is not homogeneous within the coding sequence as protein
regions that fold into a fixed 3D structure (intrinsically ordered) are under stronger selection,
especially against sites with a strong minor splice site. Investigating structures of functional protein
domains, we found that tandem acceptors are preferentially located at the domain surface and
outside structural elements such as helices and sheets. Using three-species comparisons, we
estimate that more than half of all mutations that create NAGNAG acceptors in the coding region
have been eliminated by selection.
Conclusion: We estimate that ~2,400 introns are under selection against possessing a tandem
site.
Background
Many genes in animal and plant genomes express more
than one transcript by alternative splicing. These tran-
scripts can encode proteins with different, sometimes
even antagonistic functions. For example, many members
of the human caspase gene family express alternative
splice variants that encode pro- and anti-apoptotic pro-
teins [1]. In mammals, most alternative splice events skip
complete exons or utilize either alternative donor or
acceptor splice site pairs. Most of the latter (called tandem
splice sites in the following) are in close proximity [2-6],
thus leading to the insertion/deletion (indel) of only a few
nucleotides. Alternative splice events at NAGNAG accep-
tors are the most frequent of these events. Previous studies
suggest that the splicing mechanism of short-distance tan-
dem sites involves stochastic selection of either site [7]. A
subset of these events is under purifying selection, thus
contributing to the repertoire of biologically relevant
alternative splice events [8].
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In humans, a substantial number of alternative splice
events either shift the protein reading frame or directly
introduce a premature termination codon by skipping of
exons or alternative usage of tandem splice sites [3,9-11].
Most of these events render the transcript a target for non-
sense-mediated mRNA decay (NMD) [11]. Conservation
of such events implies functionality, maybe by regulating
the protein level [8,12-14]. On the other hand, many of
these events likely have no functional relevance or may be
due to splicing errors [15]. Here, NMD is an important
surveillance mechanism reducing the amount of tran-
scripts that would be translated to truncated proteins [16].
Apart from NMD, cells can use the complex splicing regu-
latory mechanisms to silence deleterious splice events. For
example, pseudo exons (silent intronic regions that
resemble real exons) are enriched in binding sites for
silencing splicing factors, which prevent their inclusion
into the mature transcript [17]. Likewise, silencer motifs
located between two alternative splice sites inhibit the use
of one splice site [18]. Thus, auxiliary splicing enhancer
and silencer signals enable a high splicing fidelity, despite
the occurrence of numerous pseudo splice sites. Conse-
quently, there seems to have been no need to get rid of all
these pseudo splice sites in the course of evolution.
This situation is different for deleterious short-distance
tandem splice sites that preserve the reading frame. Firstly,
they do not elicit NMD and secondly, mechanisms to
inhibit the use of the alternative splice site seem to be lim-
ited. The latter reason is due to spatial restrictions that do
not allow the placement of splicing silencer motifs
between two splice sites separated by as few as 3 nucle-
otides (nt).
Furthermore, core components of the spliceosome are
likely to be the major factors that enable such alternative
splice events, whereas other splice events often depend on
additional enhancing and/or silencing splicing factors.
This makes tandem splice events rather independent of
tissue-specific fluctuations in splicing factor concentra-
tions. Consistently, many tandem sites produce constant
splice variant ratios [19-21], although variation in the
ratio was observed in several cases [4,20,22-24]. Assuming
that splicing regulatory mechanisms in general cannot
completely inhibit alternative splicing at these sites, the
ultimate option to get rid of a deleterious tandem splice
event is to destroy the tandem site, for example by a muta-
tion that destroys one GT/GC donor or one AG acceptor
dinucleotide. Under this assumption, we would expect to
find traces of natural selection, evident as an underrepre-
sentation of tandem splice sites at places where they are
deleterious.
To test this hypothesis, we analyzed frame-preserving tan-
dem splice sites with a distance of 3, 6, and 9 nt (∆3, ∆6,
and ∆9 nt, respectively). We focused on short-distance
sites because a stochastic splicing mechanism is likely to
be the basis for such alternative splice events [7]. We
present multiple lines of evidence that such tandem sites
are underrepresented in protein-coding sequences (CDS),
and in particular in regions that form ordered 3D protein
structures. We estimate that ~2,400 introns are under
selection against possessing a tandem site.
Results
Underrepresentation of tandem splice sites in coding 
regions
We used human RefSeq transcript exon-intron structures
and a series of stringent filtering steps (see Methods) to
create a data set of 15,511 protein coding genes. Each gene
is represented by a single transcript. These genes contain
140,975 introns that reside within the CDS and 9,077
introns in the 5' or 3' untranslated region (UTR). In the
following, we analyze ∆3, ∆6, and ∆9 tandem donor and
acceptor sites, where the occurrence of alternative splicing
could be inferred from mRNA/EST data.
We found that 0.26% of the CDS introns have a tandem
donor (100, 142, 127 for ∆3, ∆6, ∆9, respectively) and
1.25% a tandem acceptor (1,396, 238, 132). In contrast,
UTR introns, where such subtle events are expected to be
neutral or only slightly deleterious, have a more than 2-
fold higher fraction of tandem donors and acceptors
(0.64% and 2.54%, respectively, Fisher's exact test: P <
0.0001, Figure 1). This suggests a general underrepresen-
tation of tandem splice events in coding regions and is
consistent with a report for NAGNAG sites [7].
Inhomogeneous distribution of tandem sites in ordered and 
disordered protein regions
Next, we analyzed if this underrepresentation is homoge-
neous within the CDS. We divided the proteins into
regions that are predicted to have an intrinsically ordered
or disordered 3D structure [25]. As shown in Figure 1B,
tandem acceptors are substantially underrepresented in
ordered regions. Tandem donors exhibit the same trend
but the underrepresentation in ordered regions is moder-
ate (Figure 1A). This moderate underrepresentation might
be due to differences in the frequency of polar and hydro-
phobic protein indels. The toleration of tandem donors in
ordered regions might be higher, since they often insert
hydrophobic residues (in particular Val [19]), which are
preferred in ordered regions [25]. We also analyzed how
frequently tandem sites affect other characteristic protein
features such as Pfam domains, transmembrane (TM) hel-
ices, signal peptides, low complexity regions, coiled coil
regions, and nuclear localization signals (NLS), which is
described in detail in the Additional File 1 (see also Addi-BMC Evolutionary Biology 2008, 8:89 http://www.biomedcentral.com/1471-2148/8/89
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tional File 2). We found that low complexity regions are
rather tolerant for tandem splice events (Additional File
3), which is consistent with observations for amino acid
indels [26]. We also found evidence that tandem sites
affecting TM helices, signal peptides, and NLS are selected
against the insertion of particular amino acids (Additional
File 1, 4, 5). Tandem sites are also significantly associated
with specific DNA and RNA binding Pfam domains
(Additional File 1, 6), consistent with reports for NAG-
NAG acceptors [4,27].
Selection against a strong minor splice site in ordered 
regions
Using EST counts as a rough measure for the frequency of
splicing at the minor splice site, we considered a minor
splice site as strong if more than 25% of the ESTs support
the minor splice variant and otherwise as weak (note that
by definition >50% of the ESTs support the major vari-
ant). For tandem donors, only 33% of the 52 events with
a strong minor site affect ordered regions compared to
57% of the 317 events with a weak site (Fisher's exact test:
P = 0.0009). Likewise, for tandem acceptors, only 22% of
the 454 events with a strong minor site affect ordered
regions compared to 36% of the 1,312 events with a weak
site (Fisher's exact test: P < 0.0001). Thus, ordered regions
are under a strong selection against events that involve an
efficient minor site.
Location of tandem splice sites with respect to protein 
secondary structures
To further test the underrepresentation of tandem splice
sites in ordered regions, we focused on Pfam domains
since these domains usually fold into a well-defined 3D
structure. We obtained the protein secondary structure as
well as the surface accessibility of residues from known
3D structures of Pfam domains. We mapped the position
of 21 and 49 introns with tandem donors and acceptors,
respectively, as previously described [28]. For compari-
son, we mapped the position of 4,015 introns without a
∆3/∆6/∆9 tandem donor or acceptor motif (called control
introns) since small in-frame splice site variations cannot
occur in these introns. Comparing the location of introns
with respect to alpha-helices, beta-sheets, and non-regular
elements, we found no difference between control introns
and introns with tandem donors. However, introns with
tandem acceptors are significantly biased against a loca-
tion in helices and sheets (Figure 2A). This tendency is
even more pronounced for NAGNAG acceptors (Addi-
tional File 7). As the exact boundaries of structural ele-
ments are sometimes difficult to determine, we further
analyzed a broader context of ± 1 residue around the
intron location. We considered an intron to be 'inside a
structural element' if this broader context is completely
inside a helix or inside a sheet. If the complete context is
inside a non-regular element or in two different structural
elements, the context is considered to be 'outside a struc-
tural element'. In this comparison, both tandem donors
and acceptors show a noticeable avoidance of structural
elements (Figure 2B). The average surface accessibility
scores are indistinguishable between control intron and
tandem donor regions, while regions with tandem accep-
tors have a significantly higher surface accessibility (Figure
2C). Finally, we found polar residues to be slightly
enriched in tandem donor and strongly enriched in tan-
dem acceptor protein contexts (Figure 2D), which is fur-
ther evidence that protein variations caused by tandem
Frequency of tandem splice sites in the CDS and UTR Figure 1
Frequency of tandem splice sites in the CDS and UTR. Each 
bar is the percentage of human introns having a tandem 
donor (A) or acceptor (B). Introns are divided into a location 
in the CDS (blue) and the UTR (green). CDS introns are fur-
ther divided into a location in ordered and disordered pro-
tein regions (light blue). Absolute numbers are given above 
the bars.
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acceptors are preferentially located on the surface of
folded domains.
Strong bias against plausible NAGNAG acceptors in 
human CDS
To further investigate selection against tandem splice sites,
we focused on NAGNAG acceptors for two reasons. First,
these acceptors comprise the largest tandem class with a
total of 7,835 acceptors. Secondly, the NAGNAG motif is
highly predictive for alternative splicing [7,19,29]. That is,
sites with the motif HAGHAG (H = A, C, or T, in the fol-
lowing called 'plausible' NAGNAG acceptors) are prefer-
entially alternatively spliced (1,253 of 2,787; 45%). In
contrast, only a small fraction of the acceptors with a
HAGGAG, GAGHAG, or GAGGAG (called 'implausible')
motif allow alternative splicing (143 of 5,048; 2.8%).
Thus, we can use the motif to classify all NAGNAG accep-
tors into those that are likely and unlikely alternatively
spliced, independent of available transcript data.
First, we compared the percentage of CDS and UTR
introns that have a plausible or implausible NAGNAG
acceptor. The frequency of plausible NAGNAG sites is 1.9-
fold lower in CDS introns compared to UTR introns (Fig-
ure 3A). In contrast, the frequency of implausible sites is
very similar in CDS and UTR introns. This shows a signif-
icant depletion of plausible sites in CDS introns (Fisher's
exact test: P < 0.0001). Consistently, AAG and CAG but
not the synonymous codons AAA and CAA have been
found to be avoided at the 5' exon boundary [30,31],
although AAG/CAG is more often part of splicing
enhancer motifs than AAA/CAA [32]. Furthermore, GAG
is not underrepresented at the 5' exon boundary com-
pared to the synonymous GAA codon [31].
To further test this, we considered NAGNAG sites in C. ele-
gans, which is the only metazoan species found so far that
lacks widespread alternative splicing at NAGNAG sites
[4,19]. Two points indicate that the simple classification
plausible/implausible is also valid for C. elegans. First, C.
elegans acceptor AGs have exactly the same preference for
the preceding nucleotide (C > T > A > G) as seen in mam-
mals [33]. Secondly, all of the 33 alternatively spliced
NAGNAG acceptors in C. elegans are plausible [19]. Thus,
although the frequency of alternative splicing at NAGNAG
sites is exceptionally low in C. elegans (20-fold lower com-
pared to humans), those that are alternatively spliced
have the same characteristics as in humans. Thus, we can
use C. elegans as another control for the underrepresenta-
tion of plausible NAGNAG acceptors in human CDS
introns. As expected, in C. elegans, we found that the fre-
quency of plausible and implausible NAGNAG sites in
UTR and CDS introns is very similar (Figure 3B). Interest-
ingly, plausible NAGNAG acceptors are even more abun-
dant than implausible ones both in UTR and CDS introns
of C. elegans. This is presumably caused by a lower fre-
quency for G at the 5' exon boundary in C. elegans (~25%)
as opposed to humans (~50%) [33].
Next, we analyzed the frequency of NAGNAG sites in
ordered and disordered regions. The frequency of introns
with plausible NAGNAG sites is 3.2-fold lower in ordered
compared to disordered regions. In contrast, the fre-
quency of introns with implausible NAGNAG acceptors is
only 1.6-fold lower in ordered regions (Figure 3C), which
is a significant difference (Fisher's exact test: P < 0.0001).
The frequency of NAGNAG sites in the other protein fea-
tures is shown in Additional File 8.
Moreover, we analyzed the distribution of evolutionary
'young' and 'old' plausible/implausible NAGNAG accep-
tors in ordered/disordered regions. As shown in Figure 4,
plausible NAGNAG sites that are human specific (not
conserved in the orthologous chimpanzee, rhesus, and
mouse introns) or human-chimpanzee specific (not con-
served in rhesus and mouse) have a significant tendency
to avoid ordered regions compared to the respective
implausible ones (Fisher's exact test: P = 0.02, P < 0.0001,
respectively). A stronger underrepresentation was
observed for evolutionary old (conserved between
human, mouse, dog, and chicken) plausible NAGNAG
acceptors (Fisher's exact test: P < 0.0001). It is noteworthy
that implausible NAGNAG acceptors resemble the
expected distribution, which is the overall number of
introns in ordered/disordered regions (Figure 4). Thus,
young and old plausible NAGNAG sites are underrepre-
sented in ordered regions, indicating that selection against
such sites is universal and more effective over large evolu-
tionary distances.
Selection against NAGNAG creating mutations
We have previously shown that a single nucleotide muta-
tion can create an alternatively spliced NAGNAG acceptor
[29]. We asked whether selection acts against single nucle-
otide substitutions creating plausible NAGNAG acceptors
by comparing CDS with UTR as well as ordered with dis-
ordered regions. We considered only base exchanges that
create a second AG dinucleotide in the context of a non-
NAGNAG acceptor. To dissect selection against NAGNAG
creations from other evolutionary pressures, we focused
only on cases where the required mutation has to occur (i)
within the exon and is synonymous (Figure 5A) or (ii)
within the intron (Figure 5B). Controlling for different
distributions in the required mutations and using implau-
sible NAGNAG creations as a control (see Methods), we
estimated the relative risk (RR) for the creation of an
implausible vs. plausible NAGNAG acceptors using the
Cochran-Mantel-Haenszel (CMH) test. An RR of 1 indi-
cates that the creation of plausible and implausible NAG-
NAG sites is equally likely, which is consistent with theBMC Evolutionary Biology 2008, 8:89 http://www.biomedcentral.com/1471-2148/8/89
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Avoidance of tandem acceptors in structured regions of Pfam domains Figure 2
Avoidance of tandem acceptors in structured regions of Pfam domains. The distribution of exon/exon junctions 
derived from control introns, introns with tandem donors and acceptors (A) in alpha-helices, beta-sheets, and non-regular ele-
ments, (B) 'inside' or 'outside' structural elements (see text), (C) with respect to the average surface accessibility, and (D) with 
respect to the average inverse hydropathy scores. Kyte-Doolittle values were used to compute hydropathy scores for the ± 5 
amino acid contexts. The values were inverted so that positive values indicate polar residues. To avoid potential biases, we 
excluded the insertion sequence of tandem donors and acceptors from the context. Different context lengths of ± 3, ± 10, or 
± 15 residues give consistent results in D (Additional File 11). P-values using a χ2 test in A and B and a Wilcoxon rank sum test 
in C and D are indicated as *: P < 0.05, **: P < 0.001, ***: P < 0.0001.
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absence of selection, while an RR > 1 indicates how much
more likely the creation of an implausible site is. Using
the RR, we can estimate how many mutations that create
plausible NAGNAG sites have been eliminated by selec-
tion.
First, we investigated the exonic creation of mouse NAG-
NAG sites inferred by comparing human acceptors with
mouse and the outgroup dog. We found that the creation
of an implausible NAGNAG site in the CDS is 2.6-fold
more likely than the creation of a plausible NAGNAG,
indicating that 62% of plausible NAGNAG creating muta-
tions have been eliminated by selection (Figure 5A). In
contrast, the creation of plausible/implausible acceptor
motifs is equally likely in UTRs (RR = 1.1). In ordered
regions, the RR of 3.3 (70% elimination) is substantially
higher than the RR of 2 (50% elimination) in disordered
regions (Figure 5A). This provides evidence for a selection
pressure against the creation of plausible NAGNAG sites
in the CDS, in particular against creations in ordered
regions.
Next, we investigated NAGNAG creation by intronic
mutations. The RR is higher for the CDS region compared
to UTRs (Figure 5B). UTRs also exhibit an RR > 1, however
the RR is estimated from sparse data and P = 0.11 does not
suggest a significant deviation from the expected RR of 1.
Consistent with our above results, ordered regions exhibit
a noticeable higher RR than disordered regions (84 vs.
66% elimination). In general, intronic mutations that cre-
ate plausible NAGNAG sites seem to be under stronger
selection than exonic synonymous ones (compare Figure
5A with 5B). This might be explained by the fact that the
upstream acceptor in a NAGNAG motif is generally the
preferred splice site [3,4]. Thus, the creation of a new AG
upstream of an existing acceptor is expected to result in
the usage of the novel acceptor in the majority of tran-
scripts. In contrast, a novel acceptor downstream should
be the minor splice site, consequently the established
transcript is predominantly expressed.
Since plausible NAGNAG sites in nematodes are rarely
alternatively spliced [4,19], we would expect a much
weaker or no selection against the creation of plausible
NAGNAG sites. To test this, we examined the creation of
NAGNAG sites in C. remanei using the genomes of C.
briggsae and the outgroup C. elegans. Considering exonic
synonymous mutations, CDS introns have an RR very
similar to UTR introns (Figure 5A). While the RR for nem-
atode CDS introns is significantly different from 1 (P <
0.0001), it is substantially lower than the RR for human
CDS introns. This is consistent with a much weaker selec-
tion against plausible NAGNAG creations in nematode
CDS. Nearly identical results were observed for NAGNAG
creation in C. briggsae (Additional File 1). Compared to
mammals, C. elegans introns have an unusual acceptor site
that lacks a branch point consensus but contains a highly
conserved TTTTCAG acceptor motif, which is a high affin-
ity binding site for the U2AF heterodimer [34]. Deviations
from this consensus were shown to affect U2AF binding
[34]. Consistent with this, we found not a single case
among 5,375 nematode introns where a NAGNAG is cre-
ated by an intronic mutation.
Discussion
We presented multiple lines of evidence that human cod-
ing sequences are under selection against in-frame tan-
dem splice events. In particular, ordered regions are under
strong selection, suggesting that even small changes (one
to three amino acid differences) might affect protein fold-
ing and function. For example, the deletion of a few resi-
dues from the Piccolo C2A domain leads to a structural
change with marked consequences for Ca2+ binding [35].
We also found that tandem acceptor caused protein varia-
Distribution of plausible and implausible NAGNAG acceptors Figure 3
Distribution of plausible and implausible NAGNAG acceptors. (A) Human and (B) C. elegans UTR vs. CDS introns; 
(C) Human CDS introns divided into a location in ordered or disordered regions. Each bar is the percentage of introns having 
a plausible (blue) or implausible (green) NAGNAG acceptor. Absolute intron numbers are given above the bars.
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tions in functional domains are preferentially located at
the surface and outside structural elements such as alpha-
helices and beta-sheets. Similar results were reported for
protein indels [26,36] and exon skipping events [28]. The
frequent class of NAGNAG acceptors, which mostly result
in the indel of only one amino acid [4], is also under
strong evolutionary constraints. Consistently, a splicing-
independent case study found phenotypic effects for two
thirds of random triplet deletions [37].
Our findings of selection against tandem splice sites sug-
gest that existing tandem sites are either (effectively) neu-
tral or might have a functional role. Alternative splicing
frequently affects protein regions that are intrinsically dis-
ordered [38]. Consistently, we found that tandem splice
sites preferentially affect disordered regions. While altera-
tions of disordered regions should not cause changes in
protein structure in general, it can change the function of
proteins [38], as disordered regions are often associated
with regulation and signalling [39].
UTRs contain secondary structures and binding sites for
proteins and non-coding RNAs that influence mRNA
export, localization, stability as well as translational effi-
ciency [40]. Thus, functional sites in UTRs are also
expected to be under selection. However, our results on
tandem sites in UTRs are consistent with neutral evolu-
tion, although individual introns can still be under selec-
tion against tandem sites.
Conclusion
We found that CDS introns but not UTR introns are under
selection against tandem sites. Thus, we can use the fre-
quency of tandem sites in UTRs to provide a rough estima-
tion of the number of CDS introns under selection against
tandem splice sites. We found that 3.68% of the UTR and
1.98% of the CDS introns have a plausible NAGNAG (Fig-
ure 3). Under neutrality, we would expect that the per-
centage for CDS introns equals that for UTR introns,
consequently we estimate 2,397 (1.7% = 3.68%–1.98%)
of the 140,975 CDS introns to be under selection against
a plausible NAGNAG acceptor. Likewise, we estimate that
536 (0.38% = 0.64%–0.26%, see Figure 1) and 1,819
(1.29% = 2.54%–1.25%) CDS introns are under selection
against tandem donor and acceptor sites, respectively. In
summary, we conclude that ~2,400 human introns are
under selection against possessing a subtle tandem splice
site inserting/deleting 3, 6, or 9 nt.
Methods
Data sets
We downloaded from the UCSC Genome Browser [41]
the human genome assembly (hg17, May 2004) and the
RefSeq annotation (refFlat.txt.gz, November 2006). We
excluded all transcripts that have only one exon, that are
candidates for NMD (stop codon >50 nt upstream of the
last exon-exon junction), that lack a start or stop codon, or
that have in-frame premature stop codons according to
the RefSeq to genome mapping. Furthermore, transcripts
with ambiguous characters were excluded. We also dis-
carded transcripts that have exons shorter than 5 nt or
introns shorter than 30 nt as they might have incorrect
exon-intron structures. To get a set of non-redundant tran-
scripts, we extracted RefSeq transcripts so that they do not
overlap any other transcript on the same strand. To
remove redundancy and strong similarity of the proteins
encoded by a RefSeq transcript, we used NCBI BLASTClust
to cluster the proteins by sequence similarity using 80%
coverage and 80% identity (parameters -L 0.8 -S 80).
Then, we kept only one protein from each cluster with
more than one entry as well as all proteins from single
clusters. This yields 15,511 non-redundant transcripts/
proteins. For C. elegans, we downloaded the genome
Distribution of evolutionary 'young' and 'old' plausible vs.  implausible NAGNAG acceptors in ordered and disordered  regions Figure 4
Distribution of evolutionary 'young' and 'old' plausi-
ble vs. implausible NAGNAG acceptors in ordered 
and disordered regions. The expected distribution is the 
overall number of introns in ordered/disordered regions.
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assembly ce2 (March 2004) and the RefSeq annotation
(refFlat.txt.gz, May 2007). All transcripts were filtered as
for human, except for omitting the NMD filter. We got
15,652 non-redundant C. elegans transcripts/proteins.
For all transcripts, we screened all splice sites for the pres-
ence of a tandem donor and acceptor ∆3, ∆6, and ∆9
motif. Annotated donors without GT/GC and acceptors
without AG intron termini were omitted. The RefSeq
annotation of the open reading frame was used to decide
if a tandem site affects the CDS. A tandem site was consid-
ered as alternatively spliced if there is at least one EST/
mRNA each that match the short and the long transcript.
For  ∆3 donor and acceptor sites, we downloaded EST
information from TassDB [42]. For ∆6 and ∆9 tandem
sites, we used BLAST against all ESTs and mRNAs. From
the analyses, we omitted 35 introns where a ∆3/∆6/∆9
tandem splice event leads to the direct insertion of a stop
codon (e.g. a CAGTAG acceptor in intron phase 0), since
most of these events result in an NMD target and our aim
is to analyze only splice events causing subtle mRNA and
protein changes. Conservation of tandem sites was
detected by analyzing the genome-wide pairwise align-
ments downloaded from the UCSC genome browser
(assemblies: human hg17, chimpanzee panTro2, rhesus
rheMac2, mouse mm7, dog canFam2, chicken galGal2)
using the genomic locus of the human tandem sites to
select the respective alignment chain.
We determined characteristic protein features for the pro-
tein sequence that corresponds to the annotated exon-
intron structure. Given that the major splice site (inferred
from EST counts) is annotated for 91.2% and 89.2% of
the tandem donors and acceptors, respectively, the anno-
tated exon-intron structure reflects the predominant pro-
tein isoform in the great majority of cases. Ordered and
disordered regions were predicted by VSL2B [25]. See
Additional File 9 for the other protein features.
Location of tandem splice sites in Pfam domains structures
We considered all Pfam domains to which at least five tan-
dem splice sites were mapped and that have a known 3D
structure. As previously described [28], pdb2pfam was
used to obtain the protein secondary structure assignment
and the surface accessibility for each residue of a domain
with known 3D structure (target domain). Then, we com-
pared the Pfam alignment (the Viterbi path) of the target
domain with the alignment of the query domain to map
the position of the query intron. Specifically, we consid-
ered the exon-exon junction that represents this intron. If
the exon-exon junction splits a codon, only this amino
acid was marked as the exon junction. If the exon junction
is located between two codons, we marked both neigh-
boring amino acids. From the mapped exon-exon junc-
tion, we inferred the location in the secondary structure
and the surface accessibility. We discarded cases where the
exon-exon junction maps to an insert or delete state. For
introns with tandem splice sites, we used the annotated
exon-exon junction, since the annotated splice site is
mostly the major site. The secondary structure assignment
from the eight DSSP states was done as follows: H, G, I
helix, E sheet, and T, S, C, B non-regular. The two states BC
are converted to EE.
NAGNAG creating mutations
We define as a 'pre-NAGNAG' acceptor a non-NAGNAG
acceptor motif that requires a single base exchange to
become a NAGNAG acceptor (e.g. AAACAG requires an A
The percentage of plausible NAGNAG creating mutations eliminated by selection Figure 5
The percentage of plausible NAGNAG creating mutations eliminated by selection. (A) exonic and synonymous 
mutations, (B) intronic mutations. The relative risk (RR) indicating how much more likely the creation of an implausible NAG-
NAG is compared to the creation of a plausible NAGNAG is given above the columns. P-values of the CMH test are indicated 
as ***: P < 0.0001, **: P < 0.001, *: P < 0.01.
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to G target mutation at position 3). Based on the nucle-
otide at the two N-positions, we distinguish between
plausible and implausible pre-NAGNAG sites. For all
human pre-NAGNAG acceptors, we determined the
orthologous mouse and dog site using the genome-wide
pairwise alignments from the UCSC genome browser
[41]. Then, we considered the creation of a NAGNAG site
in mouse, inferred by demanding that the outgroup dog
has no NAGNAG acceptor. Cases of NAGNAG loss in
human (i.e. NAGNAG in mouse and dog) were discarded.
Based on the high sequence similarity between human
and mouse proteins and highly similar exon-intron struc-
tures, a mouse intron should be located in the same
region (CDS/UTR, order/disorder) as the human intron.
We use the creation of implausible NAGNAG sites as a
control, considering only mutations converting a non-AG
into an AG dinucleotide (positions 2,3,5,6 in the pre-
NAGNAG motif). Thus, the nucleotides at both N-posi-
tions do not affect our results, but they determine the like-
lihood for alternative splicing at the novel NAGNAG site.
It is noteworthy that the comparison to implausible pre-
NAGNAG sites controls for the general selection to pre-
serve the polypyrimidine tract in case of intronic muta-
tions, thus observed differences can be attributed to
selection against plausible NAGNAG sites. As the six pos-
sible target mutations (C/G/T to A and A/C/T to G) are
unequally distributed between plausible and implausible
pre-NAGNAG sites (Additional File 10) and mutation
rates differ (transitions are more frequent than transver-
sions), we have to exclude these potential biases. There-
fore, we estimated the relative risk (RR) for the gain of
implausible vs. plausible NAGNAG acceptors using the
Cochran-Mantel-Haenszel (CMH) test that corrects for
the influence of the target mutation. The CMH test was
computed using the SAS software. The RR is the ratio of
the probability that an implausible NAGNAG is created
and the probability that a plausible NAGNAG is created.
To estimate what percentage of mutations that create
plausible NAGNAG sites have been eliminated by selec-
tion, we computed (1-(1/RR))*100.
C. elegans is the only nematode with a sufficiently large
transcript coverage and lacks widespread alternative splic-
ing at NAGNAG acceptors. We assume that other nema-
todes also lack widespread alternative splicing at
NAGNAG sites. This is supported by previous experimen-
tal observations that splicing regulation between both C.
elegans and C. briggsae is highly conserved [43] and by a
high conservation between C. elegans and  C. briggsae
acceptor sites [44]. Using the same procedure as above, we
analyzed the C. elegans pre-NAGNAG acceptors using
UCSC pairwise alignments of C. elegans (assembly ce4)
with C. briggsae (cb3) and C. remanei (caeRem2) to infer
NAGNAG creation in C. briggsae as well as C. remanei
(note that C. elegans is the outgroup here [45]).
Abbreviations
nt, nucleotides; NMD, nonsense-mediated mRNA decay;
CDS, coding sequence; UTR, untranslated region; EST,
expressed sequence tag; TM helix, transmembrane helix;
NLS, nuclear localization signal; RR, relative risk; CMH
test, Cochran-Mantel-Haenszel test.
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